APA (7th ed.) Citation

Moussa, M., Chakra, M. A., Dabboucy, B., Fares, Y., Dellis, A., & Papatsoris, A. (2022). The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: A randomized controlled trial. Scandinavian Journal of Urology, 56(1), 66. https://doi.org/10.1080/21681805.2021.1990994

Chicago Style (17th ed.) Citation

Moussa, Mohamad, Mohamad Abou Chakra, Baraa Dabboucy, Youssef Fares, Athanasios Dellis, and Athanasios Papatsoris. "The Safety and Effectiveness of Mirabegron in Parkinson's Disease Patients with Overactive Bladder: A Randomized Controlled Trial." Scandinavian Journal of Urology 56, no. 1 (2022): 66. https://doi.org/10.1080/21681805.2021.1990994.

MLA (9th ed.) Citation

Moussa, Mohamad, et al. "The Safety and Effectiveness of Mirabegron in Parkinson's Disease Patients with Overactive Bladder: A Randomized Controlled Trial." Scandinavian Journal of Urology, vol. 56, no. 1, 2022, p. 66, https://doi.org/10.1080/21681805.2021.1990994.